grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

November 09, 2015

Omnicell Provides The Hospital for Sick Children with Medication Automation Solutions to Promote Patient Safety

Download PDF

MOUNTAIN VIEW, Calif., Nov. 9, 2015 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) today announced that The Hospital for Sick Children (SickKids), affiliated with the University of Toronto, has selected the Company's medication automation and safety solutions. Omnicell technology is designed to help ensure the highest level of medication security and safety, and reduce operational inefficiencies in patient care. Omnicell technology is intended to efficiently distribute, store and manage inventory of medications throughout the hospital. SickKids will be installing automated medication cabinets in the patient care areas and operating rooms, as well as a system to manage controlled substances in the central pharmacy. Omnicell solutions were selected after a thorough evaluation process that included on-site demos, visits to other hospital facilities and meetings with stakeholders and hospital leaders.

Omnicell, Inc. logo.

SickKids is a premier pediatric care center in Canada with a 285-bed facility dedicated to continually improving care for children.  The Omnicell systems were developed to help enable nurses to save time on medication management tasks, so they can spend more time interacting with patients.

"In a facility of our size, we're constantly looking for ways to streamline operations and workflows so more of our time can be devoted to our patients," said Jimmy Fung, director of pharmacy at SickKids. "We look forward to implementing this technology in our facility."

"As we continue to expand our international presence, we're pleased to add a pediatric hospital with such an impeccable reputation to the Omnicell family," shared Chris Drew, executive vice president, Sales and Marketing, Omnicell. "We are keen to support The Hospital for Sick Children's mission to improve the health of children by providing the best in family-centered care."

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

More than 3,000 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Medication Adherence solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Omnicell, Inc.

News Provided by Acquire Media